Latest biotech News

Starpharma partners with UK investment firm to create Petalion Therapeutics
Opthea Appoints Sujal Shah To Its Board Of Directors
Percheron Therapeutics provides update on ATL1102 Duchenne muscular dystrophy trial
Imugene’s oncolytic virotherapy CF33 patent granted in China
Sponsors Given Opportunity To Review Proposed Benefits
Optiscan Imaging announces the appointment of US clinical and regulatory heads
Call for sessions and speakers for Australia’s biggest week in biotech
AusMedtech 2024 Programme Launched
Orthocell completes all nerve repair surgeries in Remplir US market authorisation study
Cochlear announces the resignation of non-executive director Yasmin Allen AM
Clarity Pharmaceuticals launches $121 million fully underwritten equity raising
‘Reaching this point in the development of bisantrene is a major milestone and accomplishment’
Applications open for Moderna’s 2024 Australia Fellowship Program
Cell & Gene Catalyst submits feedback on HTA consultation
Telix announces QDOSE platform partnership for personalised dosimetry in radiopharmaceutical therapy
CSIRO announces the appointment of new Australian Centre for Disease Preparedness director
LBT Innovations announces that its APAS PharmaQC product is commercially ready
Dimerix raises $20 million to continue and expand late-stage clinical trial of DMX-200
Anteris Technologies welcomes updated DurAVR THV for serious heart condition
Mesoblast says US FDA feedback indicates support for accelerated approval pathway
Clarity Pharmaceuticals says SAR-bisPSMA detects PC lesions in the 2-millimetre range
Proteomics International retains its ISO 13485 certification
‘Innovations in equality’ highlighted on International Women’s Day
AdAlta announces positive results from Phase 1 extension study of lead asset AD-214
Solar panels in your eyeballs? This engineer is looking into it
Telix announces major acquisition of Canadian-based ARTMS
Invion announces positive results from pre-clinical study of INV043
Member views sought to inform NSW’s Innovation Blueprint
AusBiotech submits feedback on TGA fees and charges consultation
Neuren Pharmaceuticals reports fourth quarter royalties from DAYBUE sales
Telix says strong revenue growth underpins investment in late-stage pipeline
Dimerix announces successful collection of data for first patients in ACTION3 trial
LBT Innovations confirms deliver of APAS PharmaQC to Thermo Fisher
IVDs used in FMT screening exempt from Class 4 IVD requirement
Certa Therapeutics’ FT011 granted US FDA fast track for systemic sclerosis
Inaugural AusMedtechInvest 2024 launched
CSIRO launches free SME programme for medtech and digital health companies
Syntara launches new blood cancer trial of lead candidate
Opthea completes enrolment in first pivotal trial with sozinibercept
CSL reports strong first half growth with immunoglobulins the highlight
Immuron reports record sales of Travelan immune supplement
NSW Women in Life Sciences Luncheon 2024 speakers announced
Cochlear upgrades earnings guidance on better than expected implant revenue
First patient receives treatment in Chimeric’s trial of CHM 0201 in AML
Competition opens to elevate early-stage medtech pitches
Deflexifol clinical data presented at ASCO Gastrointestinal Cancers Symposium
Sustainable funding sought for National One Stop Shop for clinical trials
Cell & Gene Catalyst working groups members announced